Why Choosing the Right Drug Substance CDMO Matters for Pharma Companies

Apr 02, 2026

Introduction

The development of a new therapy involves multiple stages, from discovery through commercialization. At the center of this process is drug substance manufacturing, where the active pharmaceutical ingredient (API) is produced and refined. Since this stage determines the quality, purity, and scalability of the final therapy, selecting the right development partner can significantly influence project success.

For pharmaceutical companies seeking drug development solutions, working with experienced CDMO partners can help streamline development and accelerate timelines.

Gloved researcher working with chemical solutions and lab glassware in a laboratory setting

What Is a Drug Substance?

A drug substance is the active pharmaceutical ingredient (API) responsible for a medicine's therapeutic effect. It is the biologically active component that interacts with the body to deliver the intended treatment.

During development, the drug substance is synthesized, purified, and characterized to ensure it meets strict regulatory and quality standards before being formulated into a finished drug product.

Drug Product vs Drug Substance – Understanding the Difference

Understanding drug product vs drug substance is essential in pharmaceutical manufacturing. While the drug substance refers to the active ingredient, the drug product refers to the final formulated medicine patients receive. The drug product includes the drug substance along with excipients and delivery systems.

For example, in oral solid dosage manufacturing, the API is combined with excipients and processed into tablets or capsules.

Female scientist analyzing samples under a microscope in a clinical laboratory environment

The Process of Drug Manufacturing – Step-by-Step Overview

The process of drug manufacturing generally follows several key stages:

Drug discovery and early research: This first stage involves identifying potential therapeutic targets and discovering molecules that could modulate them. Researchers conduct laboratory experiments and screening to find promising drug candidates.
Process development and scale-up: After a lead compound is identified, scientists optimize the synthesis process and develop scalable methods for producing the drug substance. This phase includes refining chemical processes, ensuring reproducibility, and preparing for larger batch production.
Drug substance manufacturing: During this step, the active pharmaceutical ingredient (API) is synthesized at scale under strict quality controls. This ensures the API meets purity, potency, and safety requirements for further development.
Drug formulation and drug product manufacturing: Here, the API is combined with excipients and processed into the final dosage form, such as tablets, capsules, or injectables. The goal is to ensure the medicine is effective, stable, and suitable for patient administration.
Packaging, quality testing, and distribution: The finished drug product is packaged, undergoes intensive quality assurance testing, and is then distributed to healthcare providers or pharmacies. This step ensures the product remains safe and effective until it reaches the patient.

Each step must meet rigorous quality standards to ensure safety and consistency.

Blue and white capsules moving along automated conveyor belt in pharmaceutical factory production line

Oral Solid Dosage Manufacturing

One of the most common pharmaceutical formats is the tablet or capsule. Oral solid dosage manufacturing involves blending the drug substance with excipients, followed by granulation, compression, encapsulation, and coating processes.

These dosage forms are widely used because they offer stability, precise dosing, and convenient administration for patients.

Why Drug Substance Manufacturing Matters

The quality of the API directly affects the final product's safety, efficacy, and reproducibility. Reliable drug substance manufacturing ensures consistent potency, controlled impurity profiles, and scalable production methods that support clinical and commercial supply.

As drug pipelines evolve, pharmaceutical companies increasingly rely on partners with integrated capabilities that combine integrated drug discovery services with process development expertise.

Choosing the Right Partner for End-to-End Drug Manufacturing

Selecting the right CDMO partner can help companies access specialized technologies, regulatory expertise, and global manufacturing capacity.

By integrating discovery support, API development, and dosage form manufacturing, experienced partners like Piramal Pharma Solutions provide comprehensive drug development solutions that simplify complex development programs and help bring new therapies to market more efficiently.

Frequently Asked Questions

What is a drug substance?

expand_more

A drug substance is the active pharmaceutical ingredient (API) responsible for a medicine's therapeutic effect.

What is the difference between a drug product and a drug substance?

expand_more

The main difference between a drug product and a drug substance is that a drug substance is the API, and a drug product is the final dosage form delivered to patients.

Why is drug substance manufacturing important?

expand_more

Drug substance manufacturing ensures the API is produced with consistent quality, purity, and scalability for clinical and commercial use.

Which Piramal sites offer drug substance services?

expand_more

The following Piramal sites provide drug substance development and manufacturing services: